Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEDY trial of telmisartan for abdominal aortic aneurysm growth
NL-OMON43808Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in abdominal aortic aneurysm (AAA) comparing Telmisartan with Placebo (2 arms). Primary endpoints: Rate of abdominal aortic aneurysm growth by maximum orthogonal diameter and Change in total infrarenal aneurysm volume. Started Jun 2014; status: active, not recruiting.
02
Drugs
telmisartan
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NL-OMON43808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43808.